Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients

Acta Neurologica Scandinavica

Volumn 100, Issue 4, 1999, Pages 238-243

  Niebroj Dobosz, Irena ^a,b   Jamrozik, Z ^a   Janik, P ^a   Hausmanowa Petrusewicz, I ^b   Kwiecinski H ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Anti neural antibodies; Autoimmunity

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GANGLIOTETRAOSYLCERAMIDE; SULFATIDE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 0032840160     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb00387.x     Document Type: Article

References (42)

1. 1. Apostolski S, Nikolic J, Bugarski-Prokoplievic C, Miletic V, Pavlovic S, Filipovic S. Serum and CSF immunological findings in ALS. Acta Neurol Scand 1991;83:96-8.
2. 2. Bartfeld H, Dham C, Donnenfeld H et al. Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune response to viral and CNS antigens. Clin Exp Immunol 1982;48:137-46.
3. 3. Oldstone MBA, Wilson CB, Perrin LH, Norris Jr FH. Evidence for immune complex formation in patients with amyotrophic lateral sclerosis. Lancet 1976;2:169-72.
4. 4. Donnenfeld H, Kascsak RJ, Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex in ALS patients. J Neuroimmunol 1984;6:51-7.
5. 5. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990;47:1210-16.
6. 6. Adams D, Kuntzer T, Burger D et al. Predictive values of anti-GM1 ganglioside antibodies in neuromuscular diseases: A study of 180 sera. J Neuroimmunol 1991;32: 223-30.
7. 7. Appel SH, Glenn Smith R, Engelhardt JI, Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 1994;24(suppl):14-19.
8. 8. Drachman DB, Kuncl RW. Amyotrophic lateral sclerosis: An unconventional autoimmune disease? Ann Neurol 1989;26:269-74.
9. 9. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 1994;17: 100-4.
10. 10. Lamb NL, Patten BM. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis. Muscle Nerve 1991;14:1021-7.
11. 11. Lange DJ, Trojaborg WE. Do GM1 antibodies induce demyelination? Muscle Nerve 1994;17:105-7.
12. 12. Chapman J, Sela BA, Wertman E, Michaelson DM. Antibodies to ganglioside GM1 in patients with Alzheimer's disease. Neurosci Lett 1988;86:235-40.
13. 13. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM. Antibodies to glycospingolipids in patients with multiple sclerosis and SLE. J Immunol 1984;132:1793-7.
14. 14. Hartung HP, Stoll G, Toyka KV. Immune reaction in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy, 3rd ed, Philadelphia: Saunders, 1993; 418-44.
15. 15. Sadiq SA, Thomas FP, Kilidireas K et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-72.
16. 16. Salazar-Grueso EF, Routbort MJ, Martin J, Dawson G, Roos RP. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol 1990;27:558-63.
17. 17. Stevens A, Weller M, Wietholter H. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1993;56:361-4.
18. 18. Ben Younes-Chennoufi A, Meininger V, Leger JM, Bouche P, Jaubereau MO, Baumann N. Antiganglioside antibodies in motor neuron diseases and peripheral neuropathies: Study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int 1992;20:353-7.
19. 19. Zielasek J, Ritter G, Magi S, Hartung HP, Toyka KV. A comparative trial of anti-glycoconjugate antibody assay: IgM antibodies to GM1. J Neurol 1994;241:475-80.
20. 20. Rowland LP Amyotrophic lateral sclerosis: Theories and therapies. Ann Neurol 1994;35:129-30.
21. 21. World Federation of Neurology Research Group on Neuromuscular Diseases: El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994;124(suppl):96-107.
22. 22. Freddo L, Yu RK, Latov N et al. Gangliosides GM1 and GD1b are antigens for IgM M protein in a patient with motor neuron disease. Neurology 1986;36:454-8.
23. 23. Schaik IN, Bossuyt PMM, Brand A, Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis. Neurology 1995;45:1570-7.
24. 24. Heidenreich F, Leifeld L, Jovin T. T-cell dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro. J Neuroimmunol 1994;49:97-105.
25. 25. Nardelli E, Anzini P, Moretto G, Rizzuto N, Steck AJ. Pattern of nervous tissue immunostaining by human anti-glycolipid antibodies. J Neurol Sci 1994;122:220-7.
26. 26. Quarles RH, Ilyas AA, Willison HJ. Antibodies to glycolipids in demyelinating disease of the human peripheral nervous system. Chem Phys Lipids 1986;42:235-48.
27. 27. Schleup IN, Steck AJ. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 1988;38:1890-2.
28. 28. Thomas FP, Adapon PH, Goldberg GP, Latov N, Hays AP. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron diseases. J Neuroimmunol 1989;21:31-9.
29. 29. Ledeen R. Gangliosides in neuron. Trends Neurosci 1985; 8:169-74.
30. 30. Svennerholm L. Structure and biology of cell membrane gangliosides. In: Ouchterlony O, Holmgren J, eds. Cholera and Related Diarrheas, Basel: Karger, 1980;80-7.
31. 31. Thomas PK, Olson Y. Microscopic anatomy and function of the connective tissue components of peripheral nerve. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral Neuropathy. Philadelphia-London Toronto: Saunders, 1984;92-120.
32. 32. Willison HJ, Chancellor AM, Paterson G et al. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. J Neurol Sci 1993;114:209-15.
33. 33. Pestronk A, Chaudry V, Feldman EL et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of anliglycolipid antibodies. Ann Neurol 1990;27:316-26.
34. 34. Sanders KA, Rowland LP, Murphy PL et al. Motor neuron diseases and amyotrophic lateral sclerosis. GM1 antibodies and paraproteinemia. Neurology 1993;43: 418-20.
35. 35. Pestronk A, Adams RN, Clawson L et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 1988;38:1457-61.
36. 36. Pestronk A, Adams RN, Cornblath D, Kuncl RW, Rachman DB, Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol 1989;25:98-102.
37. 37. Kaji R, Hirota N, Oka N et al. Anti-GM1 antibodies and impaired blood nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 1994;17:108-10.
38. 38. Pestronk A, Li F, Feldman EL et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41: 357-62.
39. 39. Pestronk A, Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997;49:1289-92.
40. 40. Simone IL, Annunziata P, Maimone D et al. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993; 114:49-55.
41. 41. Carpo M, Nobile-Orazio E, Meucci N, Scarlato D. Anti-GM1 antibodies in Guillain-Barré syndrome. Clin Neuropathol 1991;10:146.
42. 42. Ilyas AA, Quarles RH, Dalakas MC, Brady RO. Polyneuropathy with monoclonal gammopathy: Glycolipids are frequently antigens for IgM paraproteins. Proc Natl Acad Sci USA 1985;82:6697-700.